Long term following up of a study examining rituximab maintenance following autologous stem cell transplant for treatment of relpased follicular lymphoma.
Home / Resource Library / Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial